|
|
|
A Guide to Vaccine Development & Immunization
|
|
Throughout modern history, humans have been battling infectious diseases. These diseases pose significant global health issues, and the introduction of prophylactic vaccination has been critical in combatting them. The COVID-19 pandemic highlights the need for safe and effective vaccines against new pathogens. Dozens of companies and research groups are working on vaccines for COVID-19 as of April 2020.
Read the latest blog post from Lubrizol Life Science Health (LLS Health) highlighting:
-
The history of vaccines for infectious diseases
-
How vaccines work with the immune system
-
The five types of vaccines
-
Formulation considerations for improving vaccine performance
|
|
|
Lubrizol’s Commitment to Improving Lives During COVID-19
|
|
As part of the dynamic COVID-19 environment, it remains Lubrizol’s priority to protect our employees and minimize any impact within our supply chain. Our Health team’s mission is to improve patient outcomes and we are ready to help service our customers' drug product development and manufacturing needs during this critical time.
Learn more about how we are helping in the fight against COVID-19, including enabling 1 billion bottles of hand sanitizer and contributing to key medical device components and pharmaceuticals.
|
|
|
Proprietary Technologies For Drug Products
|
|
LLS Health employs a wide range of non-proprietary technologies to tackle clients’ bioavailability and formulation challenges. At times, clients may look to utilize a patented technology as part of their intellectual property strategy or they may face a problem that needs a specialized technique. LLS Health offers several proprietary technologies that may meet clients’ commercial and technical needs.
|
|
|
|
|
|
|
|
Copyright © 2020 Lubrizol Life Science Health, All rights reserved.
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Technology, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|